184 related articles for article (PubMed ID: 19258502)
1. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.
Singer S; Malz M; Herpel E; Warth A; Bissinger M; Keith M; Muley T; Meister M; Hoffmann H; Penzel R; Gdynia G; Ehemann V; Schnabel PA; Kuner R; Huber P; Schirmacher P; Breuhahn K
Cancer Res; 2009 Mar; 69(6):2234-43. PubMed ID: 19258502
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
Malz M; Weber A; Singer S; Riehmer V; Bissinger M; Riener MO; Longerich T; Soll C; Vogel A; Angel P; Schirmacher P; Breuhahn K
Hepatology; 2009 Oct; 50(4):1130-9. PubMed ID: 19585652
[TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells.
Müller B; Bovet M; Yin Y; Stichel D; Malz M; González-Vallinas M; Middleton A; Ehemann V; Schmitt J; Muley T; Meister M; Herpel E; Singer S; Warth A; Schirmacher P; Drasdo D; Matthäus F; Breuhahn K
J Pathol; 2015 Nov; 237(3):390-401. PubMed ID: 26177862
[TBL] [Abstract][Full Text] [Related]
4. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
[TBL] [Abstract][Full Text] [Related]
5. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
10. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin.
Ng DC; Lin BH; Lim CP; Huang G; Zhang T; Poli V; Cao X
J Cell Biol; 2006 Jan; 172(2):245-57. PubMed ID: 16401721
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
12. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines.
Roger S; Rollin J; Barascu A; Besson P; Raynal PI; Iochmann S; Lei M; Bougnoux P; Gruel Y; Le Guennec JY
Int J Biochem Cell Biol; 2007; 39(4):774-86. PubMed ID: 17307016
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Takeda K; Aburatani H; Oizumi S; Konishi J; Kaga K; Matsuno Y; Birrer MJ; Nishimura M; Dosaka-Akita H
Lung Cancer; 2011 May; 72(2):229-37. PubMed ID: 20884074
[TBL] [Abstract][Full Text] [Related]
14. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
15. Expression of stathmin, a microtubule regulatory protein, is associated with the migration and differentiation of cultured early trophoblasts.
Yoshie M; Kashima H; Bessho T; Takeichi M; Isaka K; Tamura K
Hum Reprod; 2008 Dec; 23(12):2766-74. PubMed ID: 18718898
[TBL] [Abstract][Full Text] [Related]
16. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.
Singer S; Ehemann V; Brauckhoff A; Keith M; Vreden S; Schirmacher P; Breuhahn K
Hepatology; 2007 Sep; 46(3):759-68. PubMed ID: 17663418
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the RASSF1A tumor suppressor gene in controlling cell migration.
Dallol A; Agathanggelou A; Tommasi S; Pfeifer GP; Maher ER; Latif F
Cancer Res; 2005 Sep; 65(17):7653-9. PubMed ID: 16140931
[TBL] [Abstract][Full Text] [Related]
18. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells.
Akino Y; Teshima T; Kihara A; Kodera-Suzumoto Y; Inaoka M; Higashiyama S; Furusawa Y; Matsuura N
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):475-81. PubMed ID: 19735871
[TBL] [Abstract][Full Text] [Related]
19. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
20. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
